Clinical Trial Update: A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating MASEI in anti-TNF blocker–treated peripheral tendinitis associated with spondyloarthropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondyloarthropathy

Snippet

Sponsor: Sun Yat-sen University | Conditions: Spondyloarthropathy | Phase 4 | Status: COMPLETED